Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
아버멕틴B1b
아버멕틴B1b · AbaMectin B1b · C-076B1b · avermectin b1b · Aviparazine B1b · Antibiotic C-076B1b · Abamectin B1b (~90%) · Dolamectin Impurity 2

식별자 및 물리적 특성
| CAS No. | 65195-56-4 |
|---|---|
| 분자식 | C47H70O14 |
| 평균 분자량 | 859 g/mol |
| 단동위원소 질량 | 858.47655692 g/mol |
| SMILES | CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O |
| InChIKey | ZFUKERYTFURFGA-PVVXTEPVSA-N |
| PubChem CID | 6858005 |
| ChEMBL | CHEMBL2079552 |
| ChEBI | CHEBI:29537 |
| EC No. | 265-611-9 |
| DTXSID | DTXSID4058239 |
| 현지명 | 아버멕틴B1b |
화학 및 물리적 성질
| XLogP | 3.5 |
|---|---|
| 극성 표면적 | 170 |
| 수소 결합 공여자 수 | 3 |
| 수소 결합 수용자 수 | 14 |
| 회전 가능 결합 수 | 7 |
| 무거운 원자 수 | 61 |
| 형식 전하 | 0 |
| 복잡도 | 1,710 |
| 의약품 | Pharmaceuticals -> Antibiotics |
| 지질 | Polyketides [PK] -> Macrolides and lactone polyketides [PK04] |
| 농약 | Acaricides, Insecticides |
| 끓는 점 | 934.6±65.0 °C(Predicted) |
| 밀도 | 1.25±0.1 g/cm3(Predicted) |
| 저장 조건 | Store at -20°C |
| 용해도 | DMSO에 용해됨 |
| 물리적 상태 | 고체 |
| pKa(산도 계수) | 12.42±0.70(Predicted) |
| 색상 | 하얀색 |
| 안정성 | Unstable in Solution, Very Hygroscopic |
| InChIKey | ZFUKERYTFURFGA-VMROQZAPNA-N |
| EPA | Avermectin B1b (65195-56-4) |
안전 및 규제
| GHS 분류 | DangerH300+H330 (96.6%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oralacute toxicity, inhalation]P203, P260, P262, P264, P270, P271, P273, P280, P284, P301+P316, P302+P352, P304+P340, P316, P318, P319, P320, P321, P330, P361+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 29 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 2 (100%) |
| 건강 영향 | Avermectins are neurotoxic and have reproductive and developmental effects. (L1826) |
| 독성 요약 | It has low solubility in water and extensive non-specific binding. It opens GABA-insensitive chloride channels, reducing membrane resistance and increasing conductance inward. (T10) |
| Signs and Symptoms | Avermectins cause irritation of skin and eyes, central nervous system depression (incoordination, tremors, lethargy, excitation, pupil dilation, coma), vomiting, convulsions and/or tremors, and respiratory failure at high doses. (L1826) |
| Carcinogen Classification | Not listed by IARC. |
| 운송 번호(UN) | 2588 |
| 포장분류 | II |
| 위험 등급 | 6.1(a) |
용도
용도
Avermectin B1b is the minor component (